Microbot Medical Toekomstige groei
Future criteriumcontroles 0/6
Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Microbot Medical te voorspellen.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Medical Equipment winstgroei | 17.7% |
Inkomstengroei | n/a |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 03 Jun 2024 |
Recente toekomstige groei-updates
Recent updates
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?
Dec 30Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?
Sep 01Here's Why We're A Bit Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation
Dec 28Microbot Medical acquires Nitiloop, terms undisclosed
Oct 07Here's Why We're Watching Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation
Sep 13Microbot Medical confirms GLP trial on track to begin later this month
Sep 02Will Microbot Medical (NASDAQ:MBOT) Spend Its Cash Wisely?
Apr 23Microbot Medical's Stryker Collaboration Makes This An Intriguing High Flier
Jan 06Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth
Dec 24We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth
Aug 27Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth
May 12We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth
Jan 27Microbot Medical's study of surgical robotic system meets endpoints
Jan 14Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2025 | N/A | N/A | N/A | N/A | 1 |
12/31/2024 | N/A | N/A | N/A | N/A | 1 |
6/30/2024 | N/A | -10 | -8 | -8 | N/A |
3/31/2024 | N/A | -10 | -8 | -8 | N/A |
12/31/2023 | N/A | -11 | -9 | -9 | N/A |
9/30/2023 | N/A | -11 | -9 | -9 | N/A |
6/30/2023 | N/A | -12 | -10 | -10 | N/A |
3/31/2023 | N/A | -13 | -12 | -12 | N/A |
12/31/2022 | N/A | -13 | -12 | -12 | N/A |
9/30/2022 | N/A | -14 | -12 | -12 | N/A |
6/30/2022 | N/A | -13 | -11 | -11 | N/A |
3/31/2022 | N/A | -12 | -10 | -10 | N/A |
12/31/2021 | N/A | -11 | -9 | -9 | N/A |
9/30/2021 | N/A | -10 | -8 | -8 | N/A |
6/30/2021 | N/A | -10 | -8 | -8 | N/A |
3/31/2021 | N/A | -9 | -7 | -7 | N/A |
12/31/2020 | N/A | -9 | -7 | -7 | N/A |
9/30/2020 | N/A | -8 | -8 | -7 | N/A |
6/30/2020 | N/A | -8 | -7 | -7 | N/A |
3/31/2020 | N/A | -7 | -6 | -6 | N/A |
12/31/2019 | N/A | -7 | -7 | -6 | N/A |
9/30/2019 | N/A | -8 | -6 | -6 | N/A |
6/30/2019 | N/A | -7 | -6 | -6 | N/A |
3/31/2019 | N/A | -8 | -7 | -7 | N/A |
12/31/2018 | N/A | -7 | -6 | -5 | N/A |
9/30/2018 | N/A | -7 | -5 | -5 | N/A |
6/30/2018 | N/A | -6 | -5 | -5 | N/A |
3/31/2018 | N/A | -8 | N/A | -5 | N/A |
12/31/2017 | N/A | -8 | N/A | -5 | N/A |
9/30/2017 | N/A | -14 | N/A | -4 | N/A |
6/30/2017 | N/A | -14 | N/A | -3 | N/A |
3/31/2017 | N/A | -11 | N/A | -1 | N/A |
12/31/2016 | N/A | -10 | N/A | -1 | N/A |
9/30/2016 | N/A | -2 | N/A | -1 | N/A |
6/30/2016 | N/A | -1 | N/A | -1 | N/A |
3/31/2016 | N/A | -1 | N/A | -1 | N/A |
12/31/2015 | N/A | -1 | N/A | -1 | N/A |
12/31/2014 | N/A | -1 | N/A | -1 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van MBOT boven de spaarquote ( 2.6% ) ligt.
Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van MBOT naar verwachting sneller zal groeien dan de markt US
Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van MBOT naar verwachting de komende 3 jaar aanzienlijk zal groeien.
Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van MBOT naar verwachting sneller zal groeien dan de markt US.
Hoge groei-inkomsten: Er wordt verwacht dat MBOT volgend jaar geen omzet zal hebben.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van MBOT naar verwachting over 3 jaar hoog zal zijn